Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFrontier Dev Regulatory News (FDEV)

Share Price Information for Frontier Dev (FDEV)

Share Price is delayed by 15 minutes
Get Live Data
462.50    1.00 (0.22%)
Bid:
457.00
Ask:
464.50
Spread: 7.50 (1.641%)
Market Cap: £160.64m
FDEV Live PriceLast checked at - London Stock Exchange

Intraday Frontier Dev Share Chart

Publisher development agreements

20 Feb 2014 07:00

RNS Number : 4904A
Frontier Developments PLC
20 February 2014
 



 

20 February 2014

 

Frontier Developments plc

 

Signs Two New Publisher Development Agreements

 

Frontier Developments plc (AIM: FDEV; "Frontier," the "Company"), a leading developer of video games with studios in Cambridge, UK and Halifax, Canada, has signed two new development agreements with a major new global publishing partner.

 

Under the contracts, Frontier will deliver two exclusive original games using its proprietary Cobra technology which will drive support for the partner's own hardware and technology eco-system.The contracts have a combined value of £3.75m, which will be earned and recognised over development milestones spanning Frontier's current and next financial year, which ends 31 May 2015.

David Braben, Frontier's Chief Executive Officer, said: 

 

"Frontier's reputation for innovative design, high quality and timely delivery creates regular opportunities for us to partner with some of the largest and very best companies in our industry.

 

"These contracts acknowledge Frontier's qualities and add two exciting new games to our project roster, both of which were ideas generated through our company-wide 'Game of the Week' incubation programme.

 

"In addition, they demonstrate the ongoing commitment to working with strategic publishing partners that forms an important part of our plan for the Company's continued development."

 

Enquiries:

 

Frontier Developments

+44 (0)1223 394 300

David Braben, CEO

David Walsh, COO

Neil Armstrong, CFO

Canaccord Genuity 

+44 (0) 207 523 8000

Simon Bridges/Cameron Duncan

Instinctif Partners

+44 (0) 20 7457 2020

Kay Larsen/Adrian Duffield

 

About Frontier Developments

 

Frontier was founded in 1994 by David Braben, co-author of the seminal Elite game. The Group has 243 full-time employees and operations in Cambridge, UK and Halifax, Nova Scotia, Canada. Frontier has a proven track record of software technology development and innovation spanning several decades of rapid technological change. Frontier has leveraged its technology to develop innovative videogames across a wide variety of different game genres and platforms, and has established relationships with globally renowned partners.

 

About Cobra

 

Frontier's Cobra software technology has been developed and evolved since 1988. Initially conceived as a solution for the problem of easily porting the same game across different target hardware devices, Cobra today supports multi-core CPU and GPU architectures of PC, console, tablet and smartphone with a modular, high performance system offering of state of the art efficiency and visual fidelity that is applicable across a wide range of game genres.

 

Cobra incorporates a framework which enables rapid development of powerful game creation tools, which offer the ability to view, tweak and review changes to content (e.g. animations, audio, 3D models etc.) on target platforms in a live game session running on that platform, without the intervention of a programmer.

 

For more details on Cobra see http://www.frontier.co.uk/our_technology/ 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGRGGUGGPUPCGRB
Date   Source Headline
1st Jun 202612:05 pmRNSEBT Share Purchase
28th May 20262:30 pmRNS-RPlanet Zoo 2 Announced
22nd May 202611:26 amRNS-RWarhammer 40,000: Chaos Gate – Deathwatch Revealed
22nd May 20269:16 amRNSHolding(s) in Company
19th May 20265:47 pmRNSHolding(s) in Company
18th May 202610:48 amRNSEBT Share Purchase
12th May 20267:00 amRNSTrading Update - FY26 Revenue & Profit Upgraded
23rd Apr 20267:00 amRNSCompletion of Share Buyback Programme
23rd Apr 20267:00 amRNSDirector/PDMR Shareholding
23rd Apr 20267:00 amRNSTransaction in Own Shares
22nd Apr 202611:05 amRNSHolding(s) in Company
22nd Apr 20267:00 amRNSDirector/PDMR Shareholding
22nd Apr 20267:00 amRNSTransaction in Own Shares
21st Apr 20267:00 amRNSTransaction in Own Shares
17th Apr 20267:00 amRNSDirector/PDMR Shareholding
17th Apr 20267:00 amRNSTransaction in Own Shares
16th Apr 20267:00 amRNSDirector/PDMR Shareholding
16th Apr 20267:00 amRNSTransaction in Own Shares
15th Apr 20267:00 amRNSDirector/PDMR Shareholding
15th Apr 20267:00 amRNSTransaction in Own Shares
14th Apr 20267:00 amRNSDirector/PDMR Shareholding
14th Apr 20267:00 amRNSTransaction in Own Shares
10th Apr 20267:00 amRNSDirector/PDMR Shareholding
10th Apr 20267:00 amRNSTransaction in Own Shares
9th Apr 20267:00 amRNSDirector/PDMR Shareholding
8th Apr 20267:00 amRNSDirector/PDMR Shareholding
8th Apr 20267:00 amRNSTransaction in Own Shares
7th Apr 20267:00 amRNSDirector/PDMR Shareholding
7th Apr 20267:00 amRNSTransaction in Own Shares
2nd Apr 20267:00 amRNSDirector/PDMR Shareholding
2nd Apr 20267:00 amRNSTransaction in Own Shares
1st Apr 20267:00 amRNSDirector/PDMR Shareholding
1st Apr 20267:00 amRNSTransaction in Own Shares
31st Mar 20267:00 amRNSDirector/PDMR Shareholding
31st Mar 20267:00 amRNSTransaction in Own Shares
30th Mar 20267:00 amRNSDirector/PDMR Shareholding
30th Mar 20267:00 amRNSTransaction in Own Shares
27th Mar 20267:00 amRNSDirector/PDMR Shareholding
27th Mar 20267:00 amRNSTransaction in Own Shares
26th Mar 20267:00 amRNSDirector/PDMR Shareholding
26th Mar 20267:00 amRNSTransaction in Own Shares
25th Mar 20267:00 amRNSDirector/PDMR Shareholding
25th Mar 20267:00 amRNSTransaction in Own Shares
24th Mar 20267:00 amRNSDirector/PDMR Shareholding
24th Mar 20267:00 amRNSTransaction in Own Shares
23rd Mar 20267:00 amRNSDirector/PDMR Shareholding
23rd Mar 20267:00 amRNSTransaction in Own Shares
20th Mar 20267:00 amRNSDirector/PDMR Shareholding
20th Mar 20267:00 amRNSTransaction in Own Shares
19th Mar 20267:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.